RR (95% CI) of BCC and SCC by group of serum selenium concentration at baseline in 485 participants of the Nambour Skin Cancer Study, 1996-2004
. | Selenium concentration . | . | . | Ptrend . | ||||
---|---|---|---|---|---|---|---|---|
. | Group 1 . | Group 2 . | Group 3 . | . | ||||
Median (μmol/L*; min-max) | 0.9 (0.4-1.0) | 1.1 (1.1-1.2) | 1.4 (1.3-2.8) | |||||
BCC: person-based | ||||||||
No. persons affected/total participants | 33/194 | 28/163 | 16/128 | |||||
Basic RR (95% CI)† | 1.00 | 1.02 (0.61-1.69) | 0.67 (0.37-1.22) | 0.19 | ||||
Multivariate RR (95% CI)‡ | 1.00 | 0.97 (0.58-1.61) | 0.58 (0.32-1.07) | 0.08 | ||||
BCC: tumor-based | ||||||||
No. tumors/total participants | 20/163 | 22/159 | 17/163 | |||||
Basic RR (95% CI)† | 1.00 | 1.09 (0.56-2.10) | 0.57 (0.28-1.17) | 0.14 | ||||
Multivariate RR (95% CI)‡ | 1.00 | 1.02 (0.56-1.87) | 0.43 (0.21-0.86) | 0.02 | ||||
SCC: person-based | ||||||||
No. persons affected/total participants | 27/194 | 21/163 | 11/128 | |||||
Basic RR (95% CI)† | 1.00 | 0.92 (0.52-1.63) | 0.54 (0.27-1.08) | 0.08 | ||||
Multivariate RR (95% CI)‡ | 1.00 | 0.89 (0.49-1.60) | 0.49 (0.24-0.99) | 0.05 | ||||
SCC: tumor-based | ||||||||
No. tumors/total participants | 17/162 | 21/158 | 21/165 | |||||
Basic RR (95% CI)† | 1.00 | 0.97 (0.48-1.95) | 0.44 (0.19-1.00) | 0.06 | ||||
Multivariate RR (95% CI)‡ | 1.00 | 0.86 (0.44-1.67) | 0.36 (0.15-0.82) | 0.02 |
. | Selenium concentration . | . | . | Ptrend . | ||||
---|---|---|---|---|---|---|---|---|
. | Group 1 . | Group 2 . | Group 3 . | . | ||||
Median (μmol/L*; min-max) | 0.9 (0.4-1.0) | 1.1 (1.1-1.2) | 1.4 (1.3-2.8) | |||||
BCC: person-based | ||||||||
No. persons affected/total participants | 33/194 | 28/163 | 16/128 | |||||
Basic RR (95% CI)† | 1.00 | 1.02 (0.61-1.69) | 0.67 (0.37-1.22) | 0.19 | ||||
Multivariate RR (95% CI)‡ | 1.00 | 0.97 (0.58-1.61) | 0.58 (0.32-1.07) | 0.08 | ||||
BCC: tumor-based | ||||||||
No. tumors/total participants | 20/163 | 22/159 | 17/163 | |||||
Basic RR (95% CI)† | 1.00 | 1.09 (0.56-2.10) | 0.57 (0.28-1.17) | 0.14 | ||||
Multivariate RR (95% CI)‡ | 1.00 | 1.02 (0.56-1.87) | 0.43 (0.21-0.86) | 0.02 | ||||
SCC: person-based | ||||||||
No. persons affected/total participants | 27/194 | 21/163 | 11/128 | |||||
Basic RR (95% CI)† | 1.00 | 0.92 (0.52-1.63) | 0.54 (0.27-1.08) | 0.08 | ||||
Multivariate RR (95% CI)‡ | 1.00 | 0.89 (0.49-1.60) | 0.49 (0.24-0.99) | 0.05 | ||||
SCC: tumor-based | ||||||||
No. tumors/total participants | 17/162 | 21/158 | 21/165 | |||||
Basic RR (95% CI)† | 1.00 | 0.97 (0.48-1.95) | 0.44 (0.19-1.00) | 0.06 | ||||
Multivariate RR (95% CI)‡ | 1.00 | 0.86 (0.44-1.67) | 0.36 (0.15-0.82) | 0.02 |